Hirunpatravong Pradtana, Kasemsup Tharnsook, Ayudhya Woravipa Na, Apiwattanasawee Polporn
Department of Ophthalmology, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
Department of Otolaryngology, Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
J Curr Glaucoma Pract. 2019 Sep-Dec;13(3):94-98. doi: 10.5005/jp-journals-10078-1262.
Prevalence of glaucoma is higher in obstructive sleep apnea (OSA) patients. The gold standard technique to treat OSA is continuous positive airway pressure (CPAP) therapy. The influence of long-term CPAP therapy on intraocular pressure (IOP), blood pressure, ocular perfusion pressure (OPP), and glaucoma progression in primary open-angle glaucoma (POAG) patients was evaluated.
Prospective study.
In this study, we enrolled 12 eyes from six POAG patients aged >35 years, with newly diagnosed OSA and with indication for CPAP therapy. The CPAP was performed for 12 months. We monitored the IOP every 3 months. Visual field was determined at baseline and 12 months.
The mean IOP after CPAP therapy for 12 months was significantly higher than the mean baseline IOP (average IOP 3 months before CPAP therapy) (19.08 ± 3.47 vs 17.83 ± 2.88 mm Hg; = 0.006). The IOP rising rate was 0.69 ± 0.47/years ( = 0.138) before CPAP therapy and increased to 1.13 ± 0.47/years ( = 0.016) after CPAP therapy. The OPP after 12 months of CPAP was significantly lower than the baseline (42.21 ± 5.29 vs 45.24 ± 7.09 mm Hg; = 0.06). Results showed that the pattern standard deviation (PSD) value of 24-2 short wavelength automated perimetry (SWAP) visual field was reduced from 5.34 ± 3.92 to 4.77 ± 3.73 ( = 0.025). Antiglaucoma medication was administered to a patient due to increased IOP without glaucoma progression evidence.
The POAG and OSA patients demonstrated significant IOP rising after CPAP therapy but did not show progression of glaucomatous damage. Mean deviation (MD), PSD, and visual field index (VFI) were not significantly different after CPAP therapy.
PRÉCIS: Prospective study of POAG and OSA patients demonstrated significant IOP rising after CPAP therapy for a year. The study did not show progression of glaucomatous damage.
Hirunpatravong P, Kasemsup T, Ayudhya WN, Long-term Effect of Continuous Positive Air Pressure Therapy on Intraocular Pressure in Patients with Primary Open-angle Glaucoma with Obstructive Sleep Apnea. J Curr Glaucoma Pract 2019;13(3):94-98.
阻塞性睡眠呼吸暂停(OSA)患者青光眼的患病率较高。治疗OSA的金标准技术是持续气道正压通气(CPAP)治疗。评估了长期CPAP治疗对原发性开角型青光眼(POAG)患者眼压(IOP)、血压、眼灌注压(OPP)和青光眼进展的影响。
前瞻性研究。
在本研究中,我们纳入了6例年龄>35岁、新诊断为OSA且有CPAP治疗指征的POAG患者的12只眼。CPAP治疗持续12个月。我们每3个月监测一次眼压。在基线和12个月时测定视野。
CPAP治疗12个月后的平均眼压显著高于基线平均眼压(CPAP治疗前3个月的平均眼压)(19.08±3.47 vs 17.83±2.88 mmHg;P = 0.006)。CPAP治疗前眼压上升率为0.69±0.47/年(P = 0.138),CPAP治疗后升至1.13±0.47/年(P = 0.016)。CPAP治疗12个月后的眼灌注压显著低于基线(42.21±5.29 vs 45.24±7.09 mmHg;P = 0.06)。结果显示,24-2短波长自动视野计(SWAP)视野的模式标准偏差(PSD)值从5.34±3.92降至4.77±3.73(P = 0.025)。一名患者因眼压升高而给予抗青光眼药物治疗,但无青光眼进展证据。
POAG和OSA患者在CPAP治疗后眼压显著升高,但未显示青光眼损害进展。CPAP治疗后平均偏差(MD)、PSD和视野指数(VFI)无显著差异。
对POAG和OSA患者的前瞻性研究表明,CPAP治疗一年后眼压显著升高。该研究未显示青光眼损害进展。
Hirunpatravong P, Kasemsup T, Ayudhya WN, 持续气道正压通气治疗对原发性开角型青光眼合并阻塞性睡眠呼吸暂停患者眼压的长期影响。《当代青光眼实践杂志》2019;13(3):94-98。